{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:48:36Z","timestamp":1781531316702,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jaad.2014.01.914","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T08:15:15Z","timestamp":1396253715000},"page":"1036-1044.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma"],"prefix":"10.1016","volume":"70","author":[{"given":"Sara","family":"Harcharik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Moskalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Sivendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Castillo-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cordon-Cardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Sivendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.01.914_bib1","first-page":"220","article-title":"Cancer treatment and survivorship statistics","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2014.01.914_bib2","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2014.01.914_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cncr.21594","article-title":"Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma","volume":"106","author":"Ben-Porat","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2014.01.914_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.01.914_bib5","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.01.914_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02071520","article-title":"Predicting survival and recurrence in localized melanoma: a multivariate approach","volume":"16","author":"Soong","year":"1992","journal-title":"World J Surg"},{"key":"10.1016\/j.jaad.2014.01.914_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A","article-title":"Factors affecting survival following local, regional, or distant recurrence from localized melanoma","volume":"67","author":"Soong","year":"1998","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jaad.2014.01.914_bib8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2011.38.8561","article-title":"Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.01.914_bib9","doi-asserted-by":"crossref","first-page":"192719","DOI":"10.1155\/2012\/192719","article-title":"Lessons from cancer immunoediting in cutaneous melanoma","volume":"2012","author":"Aris","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaad.2014.01.914_bib10","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.01.914_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/PAT.0b013e328355767e","article-title":"A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service","volume":"44","author":"Monshizadeh","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.jaad.2014.01.914_bib12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2002-07-2206","article-title":"CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation","volume":"102","author":"Crawford","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.01.914_bib13","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1073\/pnas.112212699","article-title":"CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance","volume":"99","author":"Tibaldi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2014.01.914_bib14","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.1101640","article-title":"Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors","volume":"187","author":"Sabry","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2014.01.914_bib15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.168.3.1145","article-title":"Synergistic T cell activation via the physiological ligands for\u00a0CD2 and the T cell receptor","volume":"168","author":"Bierer","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2014.01.914_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/339312a0","article-title":"CD2-mediated adhesion facilitates T lymphocyte antigen recognition function","volume":"339","author":"Moingeon","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2014.01.914_bib17","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","article-title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","volume":"106","author":"Bogunovic","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2014.01.914_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/jid.2012.283","article-title":"BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma","volume":"133","author":"Mann","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.01.914_bib19","doi-asserted-by":"crossref","unstructured":"Sivendran S, Chang R, Pham L, Pelps R, Harcharik S, Hall L, et al. Dissection of gene networks in primary melanoma tumors critical for anti-tumor surveillance in patients with stage II-III resectable disease. J of Invest Derm doi:10.1038\/jid.2014.85. Published online February 12, 2014.","DOI":"10.1038\/jid.2014.85"},{"key":"10.1016\/j.jaad.2014.01.914_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-065X.1990.tb00562.x","article-title":"Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology","volume":"114","author":"Patarroyo","year":"1990","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaad.2014.01.914_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.coi.2010.10.014","article-title":"The role of SLAM\/CD2 polymorphisms in systemic autoimmunity","volume":"22","author":"Wang","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaad.2014.01.914_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2893.2010.01338.x","article-title":"Study of cellular immune response against hepatitis E virus (HEV)","volume":"18","author":"Prabhu","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jaad.2014.01.914_bib23","first-page":"43","article-title":"Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response","volume":"74","author":"Mihm","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaad.2014.01.914_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1309\/AJCPTXMEFOVYWDA6","article-title":"Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials","volume":"133","author":"Rao","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2014.01.914_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","article-title":"Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German central malignant melanoma registry","volume":"66","author":"Leiter","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.01.914_bib26","first-page":"3343","article-title":"Differential expression of cell adhesion molecules CD54\/CD11a and CD58\/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells","volume":"53","author":"Altomonte","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2014.01.914_bib27","first-page":"3","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma","volume":"9","author":"Oble","year":"2009","journal-title":"Cancer Immunol"},{"key":"10.1016\/j.jaad.2014.01.914_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000161116","article-title":"Completeness of histopathology reporting of melanoma in a high-incidence geographical region","volume":"218","author":"Thompson","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.01.914_bib29","doi-asserted-by":"crossref","first-page":"1.e1","DOI":"10.1016\/j.jaad.2012.09.040","article-title":"Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist, part I: management of stage III disease","volume":"68","author":"Fox","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214010524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214010524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:24Z","timestamp":1759271364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214010524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0190962214010524"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.01.914","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.01.914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}